Transaction · 0000950170-25-015701

Klee Justin B.

Klee Justin B., CEO, reported a transaction classified as exercise at Amylyx Pharmaceuticals, Inc. involving 36310.000000 shares for an estimated $57006.70. Reported holdings after the transaction were 3201243.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

exerciseSEC transaction code MCEO
AMLXAmylyx Pharmaceuticals, Inc.
Filing timeFeb 07
Trade dateFeb 05, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
…
Pre-filing
…
Returns since
…

AMLX price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
AMLX since 2025-02-07Filed 573 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
exercise
Code M
Identifier
0000950170-25-015701
Common Stock
Transaction date
Feb 05, 2025
Filed Feb 07, 2025, 01:17 AM · 2d delay
Shares
36.3k sh
$157 per share
Estimated value
$5.70M
Computed from shares × price
Holdings after
3.20M sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership
+10score
Filing-only score

+10

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Co-Chief Executive Officer

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    This option is fully vested and exercisable.

Original filing · 0000950170-25-015701
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

AMLX